NEW YORK (360Dx) – Hema Diagnostic Systems has reached an exclusive deal for the distribution and sale of its Rapid 1-2-3 Hema HIV Express test in Chile, the company's parent firm, Generex Biotechnology, announced today.

The deal is with Imerlab Sociedad Comercial Limitada. Hema's test has been registered by the Chilean Ministry of Health and approved for sale in the country, Hema said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.